Beta blockers cause side effects that range from the very common and mild, like fatigue and cold fingers, to the uncommon but serious, like dangerously slow heart rates and severe breathing problems. The specific side effects you experience depend heavily on which beta blocker you take, because these drugs are not all alike. Older, nonselective agents like propranolol tend to cast a wide net across the body’s receptors, producing more side effects, while newer, selective or vasodilating agents carry a measurably lighter burden.
Slow Heart Rate and Low Blood Pressure
The most fundamental thing beta blockers do is slow down the heart and lower blood pressure. That is the whole point of the drug. But too much of a good thing becomes a side effect: bradycardia, where the heart rate drops low enough to cause dizziness, lightheadedness, or fainting. Beta blockers also slow the electrical signals traveling through the heart’s conduction system, which can lengthen the interval between the atrial and ventricular beats. In most people on a stable dose, this amounts to a minor slowing that stays within safe limits and rarely progresses beyond a mild delay in conduction.1PubMed. The effects of slow channel blockers and beta blockers on atrioventricular nodal conduction
The picture changes when beta blockers are combined with other heart-rhythm drugs. A case series examining patients hospitalized for severe bradycardia found that those taking a beta blocker alongside a sodium channel blocker had far worse outcomes than those on a beta blocker alone. The combination group included patients who developed cardiogenic shock and heart failure, and most needed aggressive treatment including temporary pacemakers. The beta-blocker-only patients, by contrast, recovered simply by stopping the medication.2PubMed Central. Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers The lesson is practical: if you are on a beta blocker and your doctor adds another rhythm-controlling drug, the risk of dangerously slow heart rates increases and warrants close monitoring.
Fatigue and Reduced Exercise Capacity
Feeling tired or sluggish is one of the complaints people on beta blockers bring up most. This is not just a vague subjective sense. Beta blockers cap how high your heart rate can climb during exertion, and that ceiling directly limits how much oxygen your muscles receive. A large study comparing exercisers on beta blockers with those not on the drugs found that peak heart rate was about 19% lower in the beta-blocker group, and maximum oxygen uptake dropped along with it.3PubMed Central. The Impact of beta blockade on the cardio-respiratory system and symptoms during exercise Your body partially compensates by pumping more blood per heartbeat, but not enough to fully close the gap.
For someone who walks to the mailbox, this reduction may barely register. For someone who runs, cycles, or does intense physical work, it can feel like hitting a wall well before you expect to. If exercise tolerance matters to you, it is worth discussing with your doctor whether a lower dose or a different beta blocker might preserve more of your capacity.
Breathing Trouble and Lung Function
Beta blockers can tighten the airways, which is a manageable nuisance for most people but a genuine danger for those with asthma or chronic obstructive pulmonary disease (COPD). The risk depends sharply on selectivity. Nonselective beta blockers like propranolol block receptors in the lungs that normally keep airways relaxed. In a direct comparison among COPD patients, propranolol was the only beta blocker that worsened baseline lung function, and it also blocked the fast-acting rescue effect of an inhaled bronchodilator. Selective beta blockers like metoprolol left the bronchodilator response intact, and celiprolol performed similarly to placebo.4CHEST. Differential Effects of β-Blockers on Pulmonary Function in COPD
At a population level, this selectivity gap translates into real clinical outcomes. A large observational study found that current users of selective beta blockers actually had a slightly lower risk of severe COPD flare-ups compared with nonusers, while current users of nonselective beta blockers had a roughly 21% higher risk.5PubMed Central. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD
For asthma specifically, a comprehensive literature review and search of global safety reports found no published cases of severe or fatal asthma linked to selective beta blockers. A global pharmacovigilance database turned up five fatalities reported in asthma patients using selective agents, but four of those deaths were attributed to unrelated causes, and the circumstances of the fifth were unclear.6PubMed Central. The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports That does not mean selective beta blockers are risk-free in asthma, but the danger has historically been overstated, and many asthma patients who genuinely need a beta blocker can tolerate a selective one under supervision.
Sleep Problems and Nightmares
Some beta blockers get into the brain more easily than others, and that difference shows up at night. Beta blockers that dissolve readily in fat, known as lipophilic agents, include propranolol, metoprolol, and pindolol. These cross the blood-brain barrier more efficiently than water-soluble (hydrophilic) agents like atenolol. A comprehensive review found that sleep disturbances, vivid dreams, nightmares, and hallucinations were generally uncommon across all beta blockers but occurred least with hydrophilic atenolol and most with propranolol and pindolol.7Pharmacology & Therapeutics. Beta-blockers and central nervous system side effects
A pharmacovigilance study quantified this pattern using global adverse-event reports and found that moderate-to-high lipophilicity beta blockers were associated with roughly 70-84% higher odds of nightmare reports compared with low-lipophilicity agents.8PubMed. β-adrenoceptor antagonists and nightmares: A pharmacoepidemiological-pharmacodynamic study Case reports have even documented violent sleep behavior, including sleepwalking and acting out dreams, triggered by propranolol.9The American Journal of Medicine. Violent Rapid Eye Movement Sleep Behavior Disorder Induced by Propranolol If you start having disturbing dreams after beginning a beta blocker, switching to a hydrophilic option is often enough to resolve the issue.
Depression and Mood Changes
The idea that beta blockers cause depression has been around for decades, but the evidence is more nuanced than the reputation. A large matched case-control study found that ever using any beta blocker was associated with a modest 19% increase in depression risk. But when the researchers looked more closely, the elevated risk was concentrated almost entirely among short-term users of propranolol specifically. Short-term propranolol users had nearly triple the odds of a depression diagnosis. Once propranolol was removed from the analysis, the risk for short-term users of all other beta blockers dropped substantially. Long-term users of any beta blocker actually had a slightly lower risk of depression than nonusers.10PubMed Central. β-Blockers and the Risk of Depression: A Matched Case–Control Study
An important detail from the same study: much of propranolol’s apparent depression risk was explained by the conditions it was prescribed for in the first place. Propranolol is commonly used off-label for anxiety, tremor, and other neuropsychiatric conditions. When the researchers restricted the analysis to patients taking propranolol for cardiovascular reasons, the risk was only modestly elevated. Among patients with a pre-existing neuropsychiatric disorder, the risk was more than six times higher, suggesting that propranolol’s association with depression partly reflects the population taking it rather than a straightforward drug effect.11PubMed Central. β-Blockers and the Risk of Depression: A Matched Case–Control Study If you are on a beta blocker other than propranolol, the evidence for a depression link is weak. If you are on propranolol and notice mood changes, it is worth a conversation with your prescriber, though it may also be worth asking whether the underlying condition being treated could be the culprit.
Weight Gain and Metabolic Effects
Beta blockers have a reputation for causing weight gain, and the data support it, at least for older-generation drugs. A systematic analysis of randomized trials lasting six months or more found that body weight was consistently higher in the beta-blocker group compared with controls, with a median difference of about 1.2 kilograms, and the gain tended to occur during the first few months of treatment.12PubMed. Beta-adrenergic receptor blockers and weight gain: A systematic analysis One mechanism behind this is that beta blockers reduce the body’s ability to burn calories through a process called facultative thermogenesis, lowering daily energy expenditure by an estimated 50 to 100 calories.13PubMed Central. Effect of Third-Generation Beta Blockers on Weight Loss in a Population of Overweight-Obese Subjects in a Controlled Dietary Regimen
Not all beta blockers are equally guilty. A head-to-head trial in patients with diabetes found that metoprolol caused an average weight gain of about 1.2 kg, while carvedilol, a vasodilating beta blocker, produced no statistically significant weight change. The difference was especially pronounced in obese patients.14PubMed. Body weight changes with beta-blocker use: results from GEMINI More broadly, nonvasodilating beta blockers tend to worsen both blood sugar control and cholesterol profiles, while vasodilating agents like carvedilol and nebivolol have more favorable effects on glucose and lipid metabolism.15PubMed. Effects of beta-blockers on glucose and lipid metabolism
A related concern for people with diabetes is that beta blockers can mask the warning signs of low blood sugar. When your blood sugar drops, your body normally responds with a racing heart and trembling, both driven by adrenaline. Beta blockers dampen those signals, so you may not recognize a hypoglycemic episode until it becomes more severe. The same masking effect applies to the symptoms of low blood pressure, which is less widely appreciated.16PubMed. Beta Blockers can Mask not only Hypoglycemia but also Hypotension
Cold Hands and Feet
Peripheral vasoconstriction, the narrowing of blood vessels in the hands and feet, is a well-known class effect of beta blockers that can leave your fingers and toes feeling uncomfortably cold or even numb. A systematic review and network meta-analysis found that about 7% of patients on beta blockers reported this symptom compared with under 5% on placebo. Atenolol and propranolol had a significantly higher risk, while pindolol, acebutolol, and oxprenolol, which have some built-in vasodilating activity, did not differ from placebo.17PubMed Central. Peripheral vasoconstriction induced by β-adrenoceptor blockers: a systematic review and a network meta-analysis For people who already have poor circulation or Raynaud’s phenomenon, this side effect can be more than a minor annoyance, and choosing a vasodilating beta blocker or a different drug class entirely may be necessary.
Sexual Dysfunction
Erectile dysfunction is one of the side effects people worry about most, and it has historically been one of the leading reasons men stop taking their beta blocker. The concern is legitimate, though the picture is more complicated than “beta blockers cause impotence.” Several proposed mechanisms connect the two: beta blockers can dampen the sympathetic nervous system’s role in arousal, reduce testosterone levels, and impair blood flow through vasoconstriction.18PubMed Central. A review of the positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice A review focused specifically on heart failure patients noted that much of the evidence linking beta blockers to erectile dysfunction comes from studies in other settings, like hypertension, and those studies often have significant methodological problems.19PubMed Central. β-Blockers and Erectile Dysfunction in Heart Failure. Between Myth and Reality.
There is also evidence that the expectation of sexual side effects may partly create them. When patients know they are taking a drug associated with erectile dysfunction, they report more problems. Beyond that nocebo effect, the choice of beta blocker matters. A randomized crossover trial comparing metoprolol with nebivolol in men with hypertension and erectile dysfunction found that metoprolol significantly worsened erectile function scores across all subtypes of erectile dysfunction, while nebivolol did not. Nebivolol also raised levels of nitric oxide, a molecule critical for blood vessel relaxation and erection, which metoprolol did not.20PubMed. Nebivolol protects erectile functions compared to Metoprolol in hypertensive men with atherogenic, venogenic, psychogenic erectile dysfunction
Skin Reactions and Psoriasis
A less talked-about side effect is the potential for beta blockers to trigger or worsen psoriasis. A study of 588 patients with psoriasis found that among the 26 who were taking a beta blocker, nearly three-quarters experienced flare-ups of their skin disease.21Journal of the American Academy of Dermatology. Beta-blocking drugs and psoriasis: A review of cutaneous side effects and retrospective analysis of their effects on psoriasis Case reports also document new-onset psoriasis in people with no prior history of the condition, including cases of erythrodermic psoriasis, a severe form involving widespread skin redness and scaling.22PubMed Central. Beta-Blocker-Induced Erythrodermic Psoriasis: A Case Report While rare, these skin reactions can appear weeks to months after starting the medication.23PubMed Central. Mechanisms of Beta-Blocker Induced Psoriasis, and Psoriasis De Novo at the Cellular Level If you have psoriasis or a family history of it, flagging that for your prescriber before starting a beta blocker is prudent.
Why You Should Never Stop Abruptly
One of the most dangerous aspects of beta blockers is what happens when you stop taking them suddenly. When the body is exposed to a beta blocker for weeks or months, it compensates by increasing the number and sensitivity of the receptors being blocked. Yank the drug away, and those upregulated receptors are suddenly exposed to your normal adrenaline levels, producing a rebound surge. A landmark study of propranolol withdrawal found that within two weeks of abrupt discontinuation, 10 out of the study patients developed serious cardiac events, including unstable angina, life-threatening arrhythmia, heart attack, and sudden death.24PubMed. Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy This is why every prescribing guide emphasizes tapering the dose gradually over a week or two rather than stopping cold.
Genetics and Why Doses Affect People Differently
If you have ever wondered why your neighbor thrives on a beta blocker that makes you feel terrible, part of the answer is genetic. Many common beta blockers, including metoprolol and timolol, are broken down by a liver enzyme called CYP2D6. About 5 to 10 percent of people of European descent carry gene variants that make this enzyme sluggish or nonfunctional. In those individuals, metoprolol clears from the body much more slowly, leading to higher drug levels from the same dose. A study found that people with two nonfunctional copies of the CYP2D6 gene had a heart rate roughly 8.5 beats per minute lower and a diastolic blood pressure about 5 mm Hg lower than people with fully functional copies, translating to nearly four times the odds of bradycardia.25PubMed. Genetic variation in the CYP2D6 gene is associated with a lower heart rate and blood pressure in beta-blocker users A systematic review and meta-analysis confirmed this pattern: patients who metabolize metoprolol poorly have greater drops in heart rate, systolic blood pressure, and diastolic blood pressure, and face a higher risk of bradycardia.26PubMed Central. CYP2D6 polymorphism and its impact on the clinical response to metoprolol: A systematic review and meta-analysis Pharmacogenomic testing is not routine for beta blockers, but if you experience unexpectedly strong effects on a standard dose, your CYP2D6 status could be the reason.
Eye Drops That Act Like Pills
Timolol eye drops, used to treat glaucoma and ocular hypertension, are a beta blocker that most people never think of as a systemic drug. They should. Roughly 80% of the drug from each drop is absorbed into the bloodstream through the nasal mucosa, completely bypassing the liver’s first-pass metabolism that normally inactivates a large portion of an oral drug.27PubMed. Cardiac safety of ophthalmic timolol The result is that a tiny eye drop can produce the same kinds of side effects as an oral beta blocker: symptomatic bradycardia, heart block, low blood pressure, fainting, and falls.28PubMed Central. Systemic Cardiac Complications of Topical Timolol: A Case of Advanced Heart Block Requiring Pacemaker Implantation
This risk is amplified in people with the slow CYP2D6 metabolism described above. A case report documented severe bradycardia, low blood pressure, and recurrent fainting in a woman using timolol eye drops who turned out to carry two nonfunctional copies of the CYP2D6 gene.29PubMed. Severe systemic adverse reactions to ophthalmic timolol in a CYP2D6 homozygous *4 allele carrier: a case report Older adults are especially vulnerable because they are more likely to be on other heart medications and less able to tolerate sudden drops in heart rate or blood pressure. If you use timolol eye drops and experience dizziness, unusual fatigue, or near-fainting, mention the eye drops to your cardiologist or primary care doctor, not just your ophthalmologist.
Falls in Older Adults
Given that beta blockers lower heart rate and blood pressure, a reasonable worry is whether they increase the risk of falls in older adults. A meta-analysis that combined original data with previously published studies found that beta blockers as a class were not associated with increased fall risk. Selective beta blockers in particular showed no meaningful association. Nonselective beta blockers, however, carried a roughly 22% higher fall risk.30PubMed Central. Beta‐blocker use and fall risk in older individuals: Original results from two studies with meta‐analysis This tracks with the broader pattern running through nearly every side-effect category: selectivity matters, and nonselective agents consistently produce more problems.
Beta Blockers in Pregnancy
Beta blockers are sometimes prescribed during pregnancy for conditions like high blood pressure or certain heart rhythm problems, but the safety picture is incomplete. A narrative review of the available literature concluded that there is conflicting evidence about adverse effects on fetal and neonatal health, partly because the safety and efficacy data for different beta blockers in pregnancy remain scarce.31PubMed Central. Beta-Blockers and Their Current Role in Maternal and Neonatal Health: A Narrative Review of the Literature. Labetalol tends to be the preferred choice in obstetric practice, but even its safety profile is based on limited evidence compared with what is available for beta blocker use in other populations. If you are pregnant or planning to become pregnant and currently take a beta blocker, the decision about whether to continue, switch, or stop is one that requires individualized medical advice.
Newer Vasodilating Beta Blockers
A recurring theme across almost every side effect discussed here is that newer, vasodilating beta blockers, especially nebivolol and carvedilol, tend to perform better than older agents. Nebivolol stands out because it stimulates the release of nitric oxide from blood vessel walls, which counteracts many of the classic beta-blocker side effects. It does not appear to worsen cholesterol or insulin sensitivity the way traditional beta blockers can, and its tolerability profile, particularly regarding fatigue and sexual dysfunction, is consistently better in studies.32PubMed. Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release Carvedilol, while not identical in mechanism, similarly avoids the metabolic penalty of older agents in weight-gain and glucose-control studies.
None of this means that older beta blockers are bad drugs. Propranolol remains irreplaceable for some conditions, metoprolol has decades of outcomes data in heart failure, and atenolol is cheap and widely available. But when side effects are a concern, the choice of which beta blocker to prescribe is not just a matter of habit or cost. It can meaningfully determine whether someone tolerates their medication well enough to keep taking it, and adherence is often where the real health benefit is won or lost.